SCHEMBL30825976

SCHEMBL30825976

CN1CCN(c2ccc(O)nc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.49
HTR3A P46098 2/20 0.49
GAA P10253 2/20 0.49
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
GLA P06280 1/20 0.49
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 2/20 0.48
ADRA2C P18825 2/20 0.48
GFER P55789 1/20 0.48
PTK2B Q14289 1/20 0.48
ESR2 Q92731 1/20 0.48
SIRT6 Q8N6T7 2/20 0.46
FYN P06241 2/20 0.46
HRH4 Q9H3N8 1/20 0.45
CHKA P35790 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ADRA2A P08913 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27261502 1.00 MAPT (0.49) MAPTHTR3AGAAKMT2AMEN1
SCHEMBL24422281 0.81 MAPT (0.38) MAPTHTR3AGAAKMT2AMEN1
SCHEMBL82236 0.79 MAPT (0.50) MAPTHTR3AGAAKMT2AMEN1
SCHEMBL5647111 0.79 CHRNB2 (0.40) MAPTFYN
SCHEMBL30786198 0.78 CHRNB2 (0.64) MAPTHTR3AGAAKMT2AMEN1
SCHEMBL5199765 0.78 CHRNB2 (0.64) MAPTHTR3AGAAKMT2AMEN1
SCHEMBL20037501 0.78 MAPT (0.49) MAPTHTR3AGAAKMT2AMEN1
SCHEMBL22411598 0.78 CHRNB2 (0.64) HTR3AKDM4ESIRT6
SCHEMBL29664444 0.78 MAPT (0.58) MAPTHTR3AGAAKMT2AMEN1
SCHEMBL521324 0.78 MAPT (0.58) MAPTHTR3AGAAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4590396-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF Astrazeneca AB (SE) 2025-07-30 EP disclosed
WO-2024062089-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF ASTRAZENECA AB (SE) 2024-03-28 WO disclosed